Navigation Links
Active Surveillance May Benefit Men With Low-Risk Prostate Cancer
Date:12/7/2011

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Dec. 7 (HealthDay News) -- As more men are screened for and diagnosed with low-risk prostate cancer, a new draft report released Wednesday by a U.S. National Institutes of Health panel concluded that research on the safety of "active surveillance" is needed.

Once prostate cancer is discovered, many men opt for surgery or other treatments that can have negative effects on their quality of life, including erectile dysfunction, hot flashes and problems urinating. For many of these men active surveillance might be a better option, but little is known about the consequences of such a conservative strategy, the experts noted.

"Our panel found that many men with localized low-risk prostate cancer should be closely monitored permitting their treatment to be delayed until disease progression warrants it," Dr. Patricia A. Ganz, panel chairwoman and director of prevention and control research at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, said during an afternoon news conference.

Some men with prostate cancer will benefit from immediate treatment, but others will benefit from observation, she added.

The consensus of the panel was that many men could benefit from active surveillance. And it is one of the options that should be offered, according to the panel's draft report.

According to Ganz, more than 100,000 men who are diagnosed with prostate cancer each year in the United States would be candidates for active surveillance rather than immediate treatment.

But, there is no standard protocol recommending when a man should move from active surveillance to treatment, she said.

Active surveillance is not just monitoring PSA levels, but may involve several biopsies over time or scans to see if the cancer has grown, Ganz said. Often men are not given this option, and many men are reluctant to hold off on treatment, the panel noted.

"Among the recommendations are that we teach physicians to be able to communicate the possibility of a more conservative observational strategy to men who are candidates in this low-risk group with very limited disease," Ganz said.

Among patients, the word cancer tends to set off an emotional response that encourages them to chose a more active treatment, the panel noted.

There are still many unanswered questions, the panel said. Among these are: how to identify the patients who would benefit most from active surveillance; how such a program would be conducted; the best way to present this option to patients; the best way to help patients decide on this option; the reasons for opting for active surveillance vs. active treatment; and finding out the true outcomes of this approach.

After skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society estimates that for 2011: about 241,000 new cases of prostate cancer will be diagnosed, and roughly 33,720 men will die of the disease.

About one in six American men will be diagnosed with prostate cancer during his lifetime. More than 2 million men diagnosed with the disease at some point are still alive today, the society said.

More information

For more on prostate cancer, visit the U.S. National Cancer Institute.

SOURCES: Dec. 7, 2011, news conference with Patricia A. Ganz, M.D., professor, University of California, Los Angeles Schools of Medicine and Public Health, Dec. 7, 2011, U.S. National Institutes of Health Conference statement, Role of Active Surveillance in the Management of Men With Localized Prostate Cancer


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Moffitt Cancer Center researchers find MK1775 active against sarcomas
2. More years to life and life to years through increased motivation for an active life
3. Lower income dads active in their kids health
4. Practical play: Interactive video games appear valuable for ICU patients
5. Big Tobacco knew radioactive particles in cigarettes posed cancer risk but kept quiet
6. Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes
7. Clemson researchers using interactive vision tool for driving studies
8. For Women, Active Sex Life May Mean Better Aging
9. Some Thyroid Cancer Patients May Get Radioactive Iodine Unnecessarily
10. Localized reactive badger culling raises bovine tuberculosis risk, new analysis confirms
11. Scientists identify overactive genes in aggressive breast cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Active Surveillance May Benefit Men With Low-Risk Prostate Cancer  
(Date:9/20/2017)... ... September 20, 2017 , ... The ... “Humans With Vaginas.” The goal is to ignite conversation via social media and ... products. The brand has declared September “Humans with Vaginas” month, releasing a video ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “The Trials I Face to Receive God’s Grace”: a mesmerizing ... and goals to better one’s life through God. “The Trials I Face to Receive ... the wrong places, found a love for writing. Green feels that expressing his feelings ...
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... Houston, ... entire team took Friday, September 8, and Monday, September 11, off work and rolled ... Second Baptist Church before heading to local homes to start the process of rebuilding. ...
(Date:9/20/2017)... ... 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning ... author, Jeanine Liston, a busy mother of five who used her time waiting for children ... book for over twenty years. It was a way to give some meaning to ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, M.D., ... Professional Member in recognition of his contributions to the ... as a Nephrologist at the practice of Kidney and ... kidney care and hypertension solutions. He has worked in ... of career experience, as well as expertise in kidneys, ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months after ... is pleased to announce the appointment of three new ... Wynne , Dominic Jones-Phillips and James ... Tammy Wynne ... of market access writers. She has over ten years, ...
Breaking Medicine Technology: